Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Alligator Bioscience AB ( (SE:ATORX) ) is now available.
Alligator Bioscience AB announced that May 15, 2025, marks the last day of trading for its warrants series TO 12, with the subscription period for ordinary shares running until May 19, 2025. The exercise of these warrants could significantly impact the company’s capital structure, potentially raising approximately SEK 72.3 million before issue costs and resulting in a 53.75% dilution of ordinary shares, which may influence the company’s financial strategy and stakeholder interests.
More about Alligator Bioscience AB
Alligator Bioscience AB operates in the biotechnology industry, focusing on the development of innovative antibody-based therapeutics for cancer treatment. The company is based in Lund, Sweden, and is known for its research and development efforts in immuno-oncology.
Average Trading Volume: 222,033
Current Market Cap: SEK65.83M
See more insights into ATORX stock on TipRanks’ Stock Analysis page.